Sökning: "unrelated donor"
Visar resultat 1 - 5 av 27 avhandlingar innehållade orden unrelated donor.
1. Allogeneic stem cell transplantation : patients’ and sibling donors’ perspectives
Sammanfattning : Allogeneic haematopoietic stem cell transplantation (hereafter HSCT) is an established treatment which offers a potential cure for a variety of diseases, mainly haematological malignancies. However, the treatment is also associated with significant risks of acute complications and late side effects, including mortality. LÄS MER
2. HLA polymorphism : genomic typing and impact on unrelated stem cell transplantation
Sammanfattning : The HLA (Human Leukocyte Antigen) region is the most polymorphic in the human genome. The extended polymorphism contributes to the ability both of individuals and populations to combat diversity in the pathogens to which they are exposed. LÄS MER
3. Potential Hazards for Haematopoietic Stem Cell Donors
Sammanfattning : The aim of this thesis has been to increase our knowledge about the allogeneic stem cell donation procedure and the associated risks for stem cell donors. In a first study (paper I), we described the donation procedure and short-term side effects of 1957 donors included in the Nordic Register of Haematopoietic Stem Cell Donors. LÄS MER
4. HLA and KIR gene polymorphism in hematopoietic stem cell transplantation
Sammanfattning : The major histocompatibility complex (MHC) in humans known as the Human Leukocyte Antigens (HLA) is localised to the short arm of chromosome six. The HLA class 1 antigens, HLA-A, -B and -C are highly polymorphic glycoproteins expressed on the cell surface of most nucleated cells in the body. LÄS MER
5. Allogeneic stem cell transplantation in children : identification and prevention of complications : adoptive transfer of EBV-immunity
Sammanfattning : Allogeneic stem cell transplantation (SCT) can cure leukaemia, aplastic anaemia, and some inborn errors of metabolism and immunodeficiencies in children. As only 113 of patients who need SCT have an HLA-identical sibling, the use of alternative donors has increased, to over 50% of all paediatric SCTs at our centre. LÄS MER